Crystallization (Comment) | Organism |
---|---|
in silico modeling studies, substrate (R)-N-(3-(6-(4-(1,4-dimethyl-3-oxopiperazin-2-yl)phenylamino)-4-methyl-5-oxo-4,5-dihydropyrazin-2-yl)-2-methylphenyl)-4,5,6,7-tetrahydrobenzo[b] thiophene-2-carboxamide is capable of binding in the active site with the amide bond near the molybdenum cofactor, orientated in such a way to enable potential nucleophilic attack on the carbonyl of the amide bond by the hydroxyl of the molybdenum cofactor | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P05091 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(R)-N-(3-(6-(4-(1,4-dimethyl-3-oxopiperazin-2-yl)phenylamino)-4-methyl-5-oxo-4,5-dihydropyrazin-2-yl)-2-methylphenyl)-4,5,6,7-tetrahydrobenzo[b] thiophene-2-carboxamide + H2O + O2 | i.e. GDC-0834, a Bruton's tyrosine kinase inhibitor, a potential treatment of rheumatoid arthritis. GDC-0834 | Homo sapiens | ? | compound is extensively metabolized by amide hydrolysis by both aldehyde oxidase and carboxylesterase | ? |
Synonyms | Comment | Organism |
---|---|---|
ALDH2 | - |
Homo sapiens |